219 related articles for article (PubMed ID: 8912845)
1. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
2. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
5. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
6. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
[TBL] [Abstract][Full Text] [Related]
7. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
[TBL] [Abstract][Full Text] [Related]
8. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
10. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
11. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
Kim SK; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman WN; Hong WK; Lotan R; Mao L
Cancer Res; 1996 Jun; 56(11):2519-21. PubMed ID: 8653689
[TBL] [Abstract][Full Text] [Related]
12. Fhit expression is absent or reduced in a subset of primary head and neck cancer.
Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K
Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
16. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
17. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the FHIT gene in colorectal cancers.
Thiagalingam S; Lisitsyn NA; Hamaguchi M; Wigler MH; Willson JK; Markowitz SD; Leach FS; Kinzler KW; Vogelstein B
Cancer Res; 1996 Jul; 56(13):2936-9. PubMed ID: 8674044
[TBL] [Abstract][Full Text] [Related]
19. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
20. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
